James A. McEwen
Fundador en Medical Device Development Centre .
Perfil
Dr. James A.
McEwen is a Director at Medical Device Development Centre and Chairman at Sirius Genomics, Inc. He is on the Board of Directors at Medical Device Development Centre.
Dr. McEwen was previously employed as Head-Biomedical Engineering Department by Vancouver Hospital & Health Sciences Centre.
He received his doctorate degree from the University of British Columbia.
Cargos activos de James A. McEwen
| Empresas | Cargo | Inicio |
|---|---|---|
| Medical Device Development Centre | Fundador | 01/01/1990 |
Antiguos cargos conocidos de James A. McEwen.
| Empresas | Cargo | Fin |
|---|---|---|
| Vancouver Hospital & Health Sciences Centre | Corporate Officer/Principal | 01/01/1990 |
Sirius Genomics, Inc.
 Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Presidente | - |
Formación de James A. McEwen.
| University of British Columbia | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
| Vancouver Hospital & Health Sciences Centre | |
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
| Medical Device Development Centre |
- Bolsa de valores
- Insiders
- James A. McEwen
